CUBIST PHARMACEUTICALS INC
CBST
CBST was delisted on the 21st of January, 2015.
270 hedge funds and large institutions have $5.5B invested in CUBIST PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 109 increasing their positions, 86 reducing their positions, and 41 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 86
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
2% less funds holding
Funds holding: 276 → 270 (-6)
15% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 41
29% less capital invested
Capital invested by funds: $7.7B → $5.5B (-$2.21B)
96% less call options, than puts
Call options by funds: $16.1M | Put options by funds: $446M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.5M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$42.3M |
| 3 |
Bank of New York Mellon
New York
|
+$41.7M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$36.5M |
| 5 |
HM
HealthCor Management
New York
|
+$34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$576M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$127M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$38.5M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$29.5M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$21.9M |
CBST Hedge Fund Activity: Q2 2014 in Review
270 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q2 2014, worth a combined $5.5B — down 29% from $7.7B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of CBST and 35 opened new positions — a net loss of 6 holders — while 86 trimmed existing stakes and 109 added.
The largest buyer was Fidelity Investments, adding an estimated $46.5M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $576M.
- 270 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q2 2014, down from 276 in Q1 2014.
- Funds reported $5.5B of CUBIST PHARMACEUTICALS INC stock for Q2 2014, down 29% quarter-over-quarter.
- 35 funds opened new CUBIST PHARMACEUTICALS INC positions in Q2 2014 and 41 closed out, a net change of -6 holders.
- The largest CUBIST PHARMACEUTICALS INC buyer in Q2 2014 was Fidelity Investments, an estimated $46.5M added.
- The largest CUBIST PHARMACEUTICALS INC seller in Q2 2014 was BNP Paribas Financial Markets, an estimated $576M sold.
Based on aggregated 13F filings for Q2 2014.